Chromosomal Microarray Testing in 42 Korean Patients with Unexplained Developmental Delay, Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies
Chromosomal microarray (CMA) is a high-resolution, high-throughput method of identifying submicroscopic genomic copy number variations (CNVs). CMA has been established as the first-line diagnostic test for individuals with developmental delay (DD), intellectual disability (ID), autism spectrum disor...
Saved in:
Main Authors: | Sun Ho Lee, Wung Joo Song |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2017-09-01
|
Series: | Genomics & Informatics |
Subjects: | |
Online Access: | http://genominfo.org/upload/pdf/gi-2017-15-3-82.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic Value of Microarray Method in Autism Spectrum Disorder, Intellectual Disability, and Multiple Congenital Anomalies and Some Candidate Genes for Autism: Experience of Two Centers
by: Akif AYAZ, et al.
Published: (2022-06-01) -
Advances in chromosomal microarray analysis: Transforming neurology and neurosurgery
by: Wireko Andrew Awuah, et al.
Published: (2025-01-01) -
Aid to life – Montessori pedagogy in the service of autism spectrum children
by: Monika Pawluczuk-Solarz
Published: (2024-12-01) -
Chromosomal analysis and short-term outcome of prenatally diagnosed congenital heart disease
by: Marcellino Verbeke, et al.
Published: (2025-01-01) -
How Speech–Language Pathologists Adapt This Is Me Digital Transition Portfolios to Support Individuals with Intellectual/Developmental Disabilities and Communication Challenges Across Settings
by: Eve Müller, et al.
Published: (2024-12-01)